PCAT19 and neoplasm: In vivo studies using a mouse xenograft model corroborated these findings, showing that PCAT19 knockdown leads to smaller tumor volumes and reduced expression of proteins associated with cell survival and invasion, such as Survivin, Bcl-2, and MMP-9, while increasing pro-apoptotic Bax levels (Wang and Jiang, 2022).